← Database
M&A

GLEAMER

Acquired by

RADNET

FRANCE Healthcare Services EV [100m EUR - 500m EUR] 03/2026

Target

GLEAMER

Acquirer

RADNET

Context

RadNet acquired Gleamer in an all-cash transaction to integrate its automated diagnostic and reporting solutions into the DeepHealth platform. The acquisition aims to create the world's largest provider of clinical radiology AI solutions by combining RadNet's massive US imaging volume with Gleamer's advanced multi-modality software. Gleamer will now operate as RadNet’s French subsidiary, with founder Christian Allouche continuing to lead development from Paris. The strategic goal is to automate routine imaging workflows—specifically plain-film X-rays, which represent 25% of RadNet’s volume—to drive significant cost efficiencies and diagnostic accuracy.

Target

Gleamer is a leading French MedTech company specializing in artificial intelligence for medical imaging. Its "Copilot" platform provides automated diagnostic assistance for radiologists across multiple modalities, including X-ray, Mammography, and MRI. Prior to this acquisition, Gleamer consolidated the market by acquiring Pixyl and Caerus Medical in 2025, expanding its expertise into neuro and lumbar MRI. The company serves over 700 clients in 44 countries, with its solutions supporting over 25 clinical indications.

Ent. Value

LOGIN

Equity Value

LOGIN

Multiples Analysis

EV / Revenue

N/A

EV / EBITDA

N/A

EV / EBIT

N/A

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2026
LOGIN
LOGIN
LOGIN
2025
LOGIN
LOGIN
LOGIN
Unlock for Free

Sign in to access transaction multiples for GLEAMER's acquisition by RADNET.

Other operations with GLEAMER

DateTargetCountrySectorTarget DescriptionAcquirer
06/2023GLEAMERFRANCE
Healthcare Services

Gleamer is a leading French MedTech company specializing in artificial intelligence for medical imaging. Its "Copilot" platform provides automated diagnostic assistance for radiologists across multiple modalities, including X-ray, Mammography, and MRI. Prior to this acquisition, Gleamer consolidated the market by acquiring Pixyl and Caerus Medical in 2025, expanding its expertise into neuro and lumbar MRI. The company serves over 700 clients in 44 countries, with its solutions supporting over 25 clinical indications.

SUPERNOVA INVEST / HEAL CAPITAL